Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
JIB
GLOBETECH PUBLISHING

Leukemia Breast Cancers Suppressed by Single Protein

By BiotechDaily International staff writers
Posted on 02 Feb 2012
Targeting a single protein can help combat both breast cancers and leukemia, according to two new reports. The single protein, HSP90, acts as a chaperone to protect other cellular proteins.

The study’s findings were published online January 23, 2012, in the Journal of Experimental Medicine. A team of investigators led by Ute Moll from the University of Gottingen (Germany) discovered that suppressing HSP90 activity rendered normally protected proteins susceptible to attack and destruction. One of these proteins--called migration inhibitory factor--fuels the growth of breast tumors. HSP90 inhibitors slowed the growth of migration inhibitory factor (MIF)-expressing breast tumors in mice but had little effect on tumors lacking MIF.

HSP90 inhibitors also look promising for certain forms of leukemia, according to a study by David Weinstock and coworkers at the Dana-Farber Cancer Institute (Boston, MA, USA). They demonstrated that HSP90 inhibitors slowed the growth of leukemia driven by hyperactive versions of the enzyme JAK2 (Janus kinase 2), many of which become resistant to JAK2-blocking drugs. The HSP90 inhibitors delayed the growth of resistant leukemia cells in mice.

According to the scientists, this research suggests that HSP90 may represent a therapeutic target for a range of cancers.

Related Links:

University of Göttingen
Dana-Farber Cancer Institute





comments powered by Disqus

Channels

Genomics/Proteomics

view channel

Molecular Pathway Decreases Cell Adhesion and Initiates Metastasis

A recent paper outlined a molecular pathway that enables lung cancer cells to migrate away from the site of the primary tumor and become established in other parts of the body. Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) linked a virtual alphabet soup of genes and their protein products... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.